Allgemein

03 May, 2024 in Allgemein

Company update: Ansgar Santel appointed as new CEO

27 December, 2023 in Allgemein

Press release grant of EP patent

25 October, 2023 in Allgemein

New article alert: “Cationic LNP-formulated mRNA expressing Tie2-agonist in the lung endothelium prevents pulmonary vascular leakage”.

11 October, 2023 in Allgemein

New article alert: “The PTXΔLNP® Platform: On the Promise of Developing New LNPs for Tomorrow’s mRNA Therapies”.

07 June, 2023 in Allgemein

Pantherna Therapeutics teams up with University Medicine Rostock (UMR) on exploring new opportunities for mRNA therapy in ocular disease

08 February, 2023 in Allgemein

Evaxion and Pantherna announce promising preclinical mRNA vaccine data

04 October, 2022 in Allgemein

Astellas and Pantherna Enter into a New Technology Evaluation Agreement for Research with Expanded Target Organ to Generate mRNA-Based Regenerative Medicine Programs Using Direct Reprogramming

05 September, 2022 in Allgemein

Pantherna Therapeutics collaborates with Charité – Universitätsmedizin Berlin to investigate the potential of therapeutic mRNA in autoimmune disease

15 November, 2021 in Allgemein

Astellas and Pantherna Enter into Technology Evaluation Agreement for Research of mRNA-based Regenerative Medicine.

28 May, 2021 in Allgemein

Pantherna Therapeutics to be granted 2.2 millions EFRE public funding.